Literature DB >> 1465588

Candida albicans septicemia in a premature infant successfully treated with oral fluconazole.

S Bodé1, L Pedersen-Bjergaard, K Hjelt.   

Abstract

A premature male infant, birth-weight 1460 g, was treated successfully for a Candida albicans septicemia with orally administered fluconazole for 20 days. Dosage was 5 mg/kg/day. No side effects were seen. Fluconazole may present a major progress in treatment of invasive C. albicans infections in neonatology.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1465588     DOI： 10.3109/00365549209054656

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN： 0036-5548


  5 in total

Review 1.  Antifungal agents in neonatal systemic candidiasis.

Authors:  J N van den Anker; N M van Popele; P J Sauer
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191

2.  Pharmacokinetics of fluconazole in young infants.

Authors:  M C Nahata; K B Tallian; R W Force
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1999 Apr-Jun       Impact factor: 2.441

Review 3.  Systemic fungal infections in neonates.

Authors:  P C Ng
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-09       Impact factor: 5.747

4.  Pharmacokinetics of fluconazole in pediatric patients.

Authors:  K W Brammer; P E Coates
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-04       Impact factor: 3.267

Review 5.  Safety of fluconazole in paediatrics: a systematic review.

Authors:  Oluwaseun Egunsola; Abiodun Adefurin; Apostolos Fakis; Evelyne Jacqz-Aigrain; Imti Choonara; Helen Sammons
Journal:  Eur J Clin Pharmacol       Date:  2013-01-17       Impact factor: 2.953
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.